No plan yet to revise Covishield 84-day dose gap, clarifies govt

Earlier there were reports that government could make a move to reduce the minimum gap between two doses of the Covishield Covid-19 vaccine, but NTAGI has denied the reports

There is no proposal in consideration to change the dose interval between two Covid-19 vaccines--Covishield, Covaxin, and Sputnik V in India, National Technical Advisory Group on Immunisation's (NTAGI) chairman Dr Nk Arora said on Thursday.

Arora while speaking to ANI said, "There are several studies and programmatic data collection processes are on to assess the vaccine effectiveness. NTAGI is reviewing the vaccine effectiveness data on regular basis. Currently, there is no proposal for change in the interval of doses for COVISHIELD, COVAXIN, and SPUTNIK V under consideration."

Earlier there were reports that government could make a move to reduce the minimum gap